Ï㽶ÊÓƵ

Journal Article

1. Patel S, Walsh J, Pinnell D, Pei S, Chen W, Rojas J, Rathod A, Johnson J, Gawron A, Curtis JR, Baker JF, Cannon GW, Wu D, Lai M, Sauer BC (2024). Real-world experience with biosimilar infliximab-adba and infliximab-dyyb among infliximab-naïve patients with inflammatory bowel disease in the Veterans Health Administration. Medicine (Baltimore), 103(37), e39476. ()
2. von Rosenvinge EC, Vela SA, Paine ER, Chang MF, Hanson BJ, Taddei T, Smalley WE, Dunbar KB, Khan NH, Kahng LS, Anwar J, Zing R, Gawron A, Dominitz JA, Baffy G (2024). A Crisis in Scope: Recruitment and Retention Challenges Reported by VA Gastroenterology Section Chiefs. Fed Pract, 41(8), 256-260. ()
3. Shah I, Gawron AJ, Byrne KR, Inadomi JM (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Gastroenterology, 166(4), 549-552. ()
4. Toy G, Colletier K, Hale G, Valentine J, Gawron AJ, Sossenheimer M, Peterson K, Aparicio R, Fang JC (2023). Incidence of retained biopsy specimens after esophagogastroduodenoscopy and colonoscopy. Endosc Int Open, 11(7), E653-E659. ()
5. Robertson DJ, Dominitz JA, Beed A, Boardman KD, Del Curto BJ, Guarino PD, Imperiale TF, LaCasse A, Larson MF, Gupta S, Lieberman D, Planeta B, Shaukat A, Sultan S, Menees SB, Saini SD, Schoenfeld P, Goebel S, von Rosenvinge EC, Baffy G, Halasz I, Pedrosa MC, Kahng LS, Cassim R, Greer KB, Kinnard MF, Bhatt DB, Dunbar KB, Harford WV Jr, Mengshol JA, Olson JE, Patel SG, Antaki F, Fisher DA, Sullivan BA, Lenza C, Prajapati DN, Wong H, Beyth R, Lieb JG 2nd, Manlolo J, Ona FV, Cole RA, Khalaf N, Kahi CJ, Kohli DR, Rai T, Sharma P, Anastasiou J, Hagedorn C, Fernando RS, Jackson CS, Jamal MM, Lee RH, Merchant F, May FP, Pisegna JR, Omer E, Parajuli D, Said A, Nguyen TD, Tombazzi CR, Feldman PA, Jacob L, Koppelman RN, Lehenbauer KP, Desai DS, Madhoun MF, Tierney WM, Ho MQ, Hockman HJ, Lopez C, Carter Paulson E, Tobi M, Pinillos HL, Young M, Ho NC, Mascarenhas R, Promrat K, Mutha PR, Pandak WM Jr, Shah T, Schubert M, Pancotto FS, Gawron AJ, Underwood AE, Ho SB, Magno-Pagatzaurtundua P, Toro DH, Beymer CH, Kaz AM, Elwing J, Gill JA, Goldsmith SF, Yao MD, Protiva P, Pohl H, Kyriakides T, CONFIRM Study Group (2023). Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening Trial. JAMA Netw Open, 6(7), e2321730. ()
6. Joo YY, Pacheco JA, Thompson WK, Rasmussen-Torvik LJ, Rasmussen LV, Lin FTJ, Andrade M, Borthwick KM, Bottinger E, Cagan A, Carrell DS, Denny JC, Ellis SB, Gottesman O, Linneman JG, Pathak J, Peissig PL, Shang N, Tromp G, Veerappan A, Smith ME, Chisholm RL, Gawron AJ, Hayes MG, Kho AN (2023). Multi-ancestry genome- and phenome-wide association studies of diverticular disease in electronic health records with natural language processing enriched phenotyping algorithm. PLoS One, 18(5), e0283553. ()
7. Benson R, Winterton C, Winn M, Krick B, Liu M, Abu-El-Rub N, Conway M, Del Fiol G, Gawron A, Hardikar S (2024). Leveraging Natural Language Processing to Extract Features of Colorectal Polyps From Pathology Reports for Epidemiologic Study. JCO Clin Cancer Inform, 7, e2200131. ()
8. Gupta S, Earles A, Bustamante R, Patterson OV, Gawron AJ, Kaltenbach TR, Yassin H, Lamm M, Shah SC, Saini SD, Fisher DA, Martinez ME, Messer K, Demb J, Liu L (2022). Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy. Clin Gastroenterol Hepatol. ()
9. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta S (2022). Baseline Characteristics and Longitudinal Outcomes of Traditional Serrated Adenomas: A Cohort Study. Clin Gastroenterol Hepatol. ()
10. Trivedi M, Godil S, Demb J, Earles A, Bustamante R, Patterson OV, Gawron A, Kaltenbach T, Mahata S, Liu L, Gupta S (2022). Baseline characteristics and longitudinal outcomes of traditional serrated adenomas: a cohort study. Clin Gastroenterol Hepatol. ()
11. Demb J, Liu L, Bustamante R, Dominitz JA, Earles A, Shah SC, Gawron AJ, Martinez ME, Gupta S (2022). COVID-19 Pandemic Had Minimal Impact on Colonoscopy Completion After Colorectal Cancer Red Flag Sign or Symptoms in US Veterans. Dig Dis Sci. ()
12. Parbhu SK, Shah SC, Sossenheimer MJ, Fang JC, Peterson KA, Gawron AJ (2022). Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center. Therap Adv Gastroenterol, 15, 17562848221117640. ()
13. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz JA (2022). Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointest Endosc, 96(3), 423-432.e7. ()
14. Yadlapati R, Gawron AJ, Gyawali CP, Chen J, Clarke J, Fass R, Jain A, Lynch K, Khan A, Katz PO, Katzka DA, Richter J, Schnoll-Sussman F, Spechler SJ, Vaezi MF, Vela M, Pandolfino JE (2022). Clinical role of ambulatory reflux monitoring in PPI non-responders: Recommendation statements. Aliment Pharmacol Ther. ()
15. Gawron AJ, Sultan S, Glorioso TJ, Califano S, Kralovic SM, Jones M, Kirsh S, Dominitz JA (2022). Pre-Endoscopy COVID-19 screening and SARS-CoV-2 nucleic acid amplification testing in the VA Healthcare System: Clinical practice patterns, outcomes, and relationship to procedure volume. Gastrointest Endosc, 96(3), 423-432.e7. ()
16. Keswani RN, Wood M, Benson M, Gawron AJ, Kahi C, Kaltenbach T, Yadlapati R, Gregory D, Duloy A (2022). Individualized feedback on colonoscopy skills improves group colonoscopy quality in providers with lower adenoma detection rates. Endosc Int Open, 10(3), E232-E237. ()
17. Gawron AJ, Yao Y, Gupta S, Cole G, Whooley MA, Dominitz JA, Kaltenbach T (2020). Simplifying Measurement of Adenoma Detection Rates for Colonoscopy. Dig Dis Sci, 66(9), 3149-3155. ()
18. Kaltenbach T, Gawron A, Meyer CS, Gupta S, Shergill A, Dominitz JA, Soetikno RM, Nguyen-Vu T, A Whooley M, Kahi CJ (2021). Adenoma Detection Rate (ADR) Irrespective of Indication Is Comparable to Screening ADR: Implications for Quality Monitoring. Clin Gastroenterol Hepatol, 19(9), 1883-1889.e1. ()
19. Keswani RN, Kahi CJ, Benson M, Gawron AJ, Kaltenbach TR, Yadlapati RH, Gregory DL, Duloy A (2021). Cecal retroflexion is infrequently performed in routine practice and the retroflexed view is of poor quality. BMC Gastroenterol, 21(1), 307. ()
20. McKenzie P, Fang J, Davis J, Qiu Y, Zhang Y, Adler DG, Gawron AJ (2020). Safety of endoscopist-directed nurse-administered balanced propofol sedation in patients with severe systemic disease (ASA class III). Gastrointest Endosc, 94(1), 124-130. ()
21. Gawron AJ, Staub J, Bielefeldt K (2020). Impact of Health Insurance, Poverty, and Comorbidities on Colorectal Cancer Screening: Insights from the Medical Expenditure Panel Survey. Dig Dis Sci, 66(1), 70-77. ()
22. Derek P, Jessica J, Brian S, Shoabo P, Wei C, Jorge R, Andrew G, Joshua B, Jeffrey C, Vicki S, David W, Jessica W (2020). P022 Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans. Am J Gastroenterol, 115(Suppl 1), S6. ()
23. Gawron AJ, Kaltenbach T, Dominitz JA (2020). The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System. Gastroenterology, 159(4), 1216-1220.e1. ()
24. DeLay K, Pandolfino JE, Gyawali CP, Frye J, Kaizer A, Menard-Katcher P, Sloan JA, Gawron AJ, Peterson K, Carlson DA, Khan A, Keswani RN, Yadlapati R (2020). Esophageal Manometry Competency Program Improves Gastroenterology Fellow Performance in Motility Interpretation. Am J Gastroenterol, 115(9), 1453-1459. ()
25. Low EE, Demb J, Liu L, Earles A, Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ, Martinez ME, Gupta S (2020). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492-501.e7. ()
26. Gawron AJ, Bell R, Abu Dayyeh BK, Buckley FP, Chang K, Dunst CM, Edmundowicz SA, Jobe B, Lipham JC, Lister D, Canto MI, Smith MS, Starpoli AA, Triadafilopoulos G, Watson TJ, Wilson E, Pandolfino JE, Kaizer A, Van De Voorde Z, Yadlapati R (2020). Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel. Gastrointest Endosc, 92(1), 78-87.e2. ()
27. Shah SC, Gawron AJ, Li D (2020). Surveillance of Gastric Intestinal Metaplasia. Am J Gastroenterol, 115(5), 641-644. ()
28. Keswani RN, Benson M, Beveridge C, Gawron AJ, Gluskin AB, Kahi CJ, Kaltenbach TR, McClure J, Schenck R, Yadlapati RH, Duloy A (2019). Colonoscopy-Naïve Raters Can Be Trained to Assess Colonoscopy Quality. Clin Gastroenterol Hepatol, 18(4), 989-991.e1. ()
29. Altayar O, Davitkov P, Shah SC, Gawron AJ, Morgan DR, Turner K, Mustafa RA (2019). AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Gastroenterology, 158(3), 732-744.e16. ()
30. Davitkov P, Altayar O, Shah SC, Gawron AJ, Mustafa RA, Sultan S, Morgan DR (2019). Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations. Gastroenterology, 158(3), 751-759. ()
31. Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB (2019). Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology, 158(3), 745-750. ()
32. Shah SC, Gupta S, Li D, Morgan D, Mustafa RA, Gawron AJ (2020). Spotlight: Gastric Intestinal Metaplasia. Gastroenterology, 158(3), 704. ()
33. Demb J, Yaseyyedi A, Liu L, Bustamante R, Earles A, Ghosh P, Gutkind JS, Gawron AJ, Kaltenbach TR, Martinez ME, Gupta S (2019). Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes. Clin Transl Gastroenterol, 10(11), e00092. ()
34. Bustamante R, Earles A, Murphy JD, Bryant AK, Patterson OV, Gawron AJ, Kaltenbach T, Whooley MA, Fisher DA, Saini SD, Gupta S, Liu L (2019). Ascertainment of Aspirin Exposure Using Structured and Unstructured Large-scale Electronic Health Record Data. Med Care, 57(10), e60-e64. ()
35. Gawron A, Bielefeldt K (2019). Unrelated Death After Colorectal Cancer Screening: Implications for Improving Colonoscopy Referrals. Fed Pract, 36(6), 262-270. ()
36. McVay TR, Garrett G C, Celena B P, Klaus B, Fang JC, Chapman WW, Samore MH, Gawron AJ (2019). Natural Language Processing Accurately Identifies Dysphagia Indications for Esophagogastroduodenoscopy Procedures in a Large US Integrated Healthcare System: Implications for Classifying Overuse and Quality Measurement. AMIA Jt Summits Transl Sci Proc, 2019, 665-671. ()
37. Patel J, Fang J, Taylor LJ, Adler DG, Gawron AJ (2019). Safety and efficacy of non-anesthesiologist administration of propofol sedation during esophagogastroduodenoscopy in the intensive care unit. Endosc Int Open, 7(4), E625-E629. ()
38. Earles A, Liu L, Bustamante R, Coke P, Lynch J, Messer K, Martnez ME, Murphy JD, Williams CD, Fisher DA, Provenzale DT, Gawron AJ, Kaltenbach T, Gupta S (2019). Structured Approach for Evaluating Strategies for Cancer Ascertainment Using Large-Scale Electronic Health Record Data. JCO Clin Cancer Inform, 2, 1-12. ()
39. Gawron AJ, Lawrence P, Millar MM, Dominitz JA, Gupta S, Whooley M, Kaltenbach T (2019). A Nationwide Survey and Needs Assessment of Colonoscopy Quality Assurance Programs in the VA. Fed Pract, 35(3), 26-32. ()
40. Balbale S, Gawron A, LaVela SL (2019). Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy. Patient Exp J, 5(3), 149-159. ()
41. Gawron AJ, Pandolfino JE, Howden CE (2014). Initial proton pump inhibitor prescription characteristics associated with long-term use in US Veterans diagnosed with gastroesophageal reflux disease. J Pharm Health Serv Res, 5(3), 157-164.

Review

1. Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA (2019). AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. [Review]. Gastroenterology, 158(3), 705-731.e5. ()

Editorial

1. Shah I, Gawron AJ, Byrne KR, Inadomi JM (2024). Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities. Clin Gastroenterol Hepatol, 22(4), 679-683. ()
2. Yadlapati R, Gawron AJ, Pandolfino JE (2022). Editorial: wireless pH-monitoring - is it time to put away the pH-impredance catheters: Authors' response. Aliment Pharmacol Ther, 56(8), 1298-1299. ()
3. Gawron AJ, Dominitz JA (2022). Higher Quality Colonoscopy: Worth the Wait? Clin Transl Gastroenterol, 13(4), e00471. ()

News

• COVID-19 Prompts U of Utah Health, VA to Evaluate Use of Endoscopy
• When is Heartburn Considered Serious?

Podcasts

• Dramatic Rise in Colorectal Cancer for People under 50